SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-008158
Filing Date
2018-06-04
Accepted
2018-06-04 09:15:17
Documents
21
Period of Report
2018-06-04
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 27959
2 ex99-1.htm EX-99.1 20843
3 ex99-1_001.jpg GRAPHIC 58592
4 ex99-1_002.jpg GRAPHIC 176628
5 ex99-1_003.jpg GRAPHIC 123370
6 ex99-1_004.jpg GRAPHIC 127849
7 ex99-1_005.jpg GRAPHIC 102914
8 ex99-1_006.jpg GRAPHIC 77654
9 ex99-1_007.jpg GRAPHIC 109653
10 ex99-1_008.jpg GRAPHIC 108493
11 ex99-1_009.jpg GRAPHIC 86153
12 ex99-1_010.jpg GRAPHIC 90996
13 ex99-1_011.jpg GRAPHIC 70704
14 ex99-1_012.jpg GRAPHIC 131533
15 ex99-1_013.jpg GRAPHIC 111993
16 ex99-1_014.jpg GRAPHIC 107021
17 ex99-1_015.jpg GRAPHIC 81921
18 ex99-1_016.jpg GRAPHIC 87110
19 ex99-1_017.jpg GRAPHIC 84948
20 ex99-1_018.jpg GRAPHIC 89232
21 ex99-1_019.jpg GRAPHIC 116683
  Complete submission text file 0001493152-18-008158.txt   2728203
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-184948 | Film No.: 18877009
SIC: 2834 Pharmaceutical Preparations